Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yishen Qingdu granules for stage 4 chronic kidney disease
CTR20132069Phase 3Active
- Sponsor
- Jilin Institute of Pharmaceutical Research
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Yishen Qingdu Granules in chronic kidney disease (CKD), sponsored by Jilin Institute of Pharmaceutical Research. Started Apr 2014; status: active.
02
Drugs
Yishen Qingdu Granules
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20132069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132069.